Gaby Sroczynski

2.6k total citations · 1 hit paper
82 papers, 1.3k citations indexed

About

Gaby Sroczynski is a scholar working on Epidemiology, Oncology and Economics and Econometrics. According to data from OpenAlex, Gaby Sroczynski has authored 82 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 22 papers in Oncology and 18 papers in Economics and Econometrics. Recurrent topics in Gaby Sroczynski's work include Health Systems, Economic Evaluations, Quality of Life (17 papers), Hepatitis C virus research (16 papers) and Cervical Cancer and HPV Research (15 papers). Gaby Sroczynski is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (17 papers), Hepatitis C virus research (16 papers) and Cervical Cancer and HPV Research (15 papers). Gaby Sroczynski collaborates with scholars based in Austria, United States and Germany. Gaby Sroczynski's co-authors include Uwe Siebert, Nikolai Mühlberger, Ruth Schwarzer, Saša Rajšić, Helena Hiemisch Lobo Borba, Thomas Toell, Holger Gothe, Stefan Zeuzem, Beate Lettmeier and Beate Jahn and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hepatology.

In The Last Decade

Gaby Sroczynski

72 papers receiving 1.3k citations

Hit Papers

Economic burden of stroke: a systematic review on post-st... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Economic burden of stroke: a systematic review on post-stroke care
    2018 317 citations Saša Rajšić, Holger Gothe et al. The European Journal of Health Economics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaby Sroczynski Austria 18 684 372 189 180 154 82 1.3k
Helga Radner Austria 26 292 0.4× 97 0.3× 99 0.5× 106 0.6× 31 0.2× 69 2.4k
Paolo Angelo Cortesi Italy 20 589 0.9× 544 1.5× 157 0.8× 64 0.4× 8 0.1× 112 1.7k
Ralph Brinks Germany 24 371 0.5× 46 0.1× 100 0.5× 65 0.4× 25 0.2× 133 1.9k
Salahuddin Kazi United States 13 190 0.3× 47 0.1× 51 0.3× 106 0.6× 34 0.2× 24 1.5k
Christine Le Bihan-Benjamin France 18 379 0.6× 204 0.5× 30 0.2× 133 0.7× 16 0.1× 59 1.4k
Isao Kamae Japan 20 239 0.3× 124 0.3× 273 1.4× 82 0.5× 7 0.0× 69 1.6k
Fraser Cummings United Kingdom 26 742 1.1× 88 0.2× 124 0.7× 134 0.7× 8 0.1× 108 2.3k
Mitsumasa Kishimoto Japan 28 186 0.3× 42 0.1× 57 0.3× 154 0.9× 21 0.1× 162 2.9k
Geraldo da Rocha Castelar Pinheiro Brazil 22 138 0.2× 44 0.1× 66 0.3× 68 0.4× 30 0.2× 87 1.5k
Naomi Brewer New Zealand 14 272 0.4× 100 0.3× 136 0.7× 321 1.8× 9 0.1× 28 1.2k

Countries citing papers authored by Gaby Sroczynski

Since Specialization
Citations

This map shows the geographic impact of Gaby Sroczynski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaby Sroczynski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaby Sroczynski more than expected).

Fields of papers citing papers by Gaby Sroczynski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaby Sroczynski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaby Sroczynski. The network helps show where Gaby Sroczynski may publish in the future.

Co-authorship network of co-authors of Gaby Sroczynski

This figure shows the co-authorship network connecting the top 25 collaborators of Gaby Sroczynski. A scholar is included among the top collaborators of Gaby Sroczynski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaby Sroczynski. Gaby Sroczynski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arvandi, Marjan, et al.. (2023). Vergleich der Effektivität von multiplen dynamischen Behandlungsstrategien unter Nutzung der Target-Trial-Emulierung. Prävention und Gesundheitsförderung. 1–11.
2.
Conrads‐Frank, Annette, et al.. (2023). Stool DNA testing for early detection of colorectal cancer: systematic review using the HTA Core Model ® for Rapid Relative Effectiveness Assessment. SHILAP Revista de lepidopterología. 21. Doc06–Doc06. 2 indexed citations
3.
Crispin, Alexander, Sabine Hoffmann, Doris Lindoerfer, et al.. (2023). Colorectal cancer screening for persons with a positive family history. Deutsches Ärzteblatt international. 120(46). 786–792.
4.
Herzog, Chiara, Karin Sundström, Allison Jones, et al.. (2022). DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test. Clinical Epigenetics. 14(1). 150–150. 6 indexed citations
5.
Mühlberger, Nikolai, Gaby Sroczynski, Beate Jahn, et al.. (2021). Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies. The European Journal of Health Economics. 22(8). 1311–1344. 21 indexed citations
6.
Sroczynski, Gaby, et al.. (2020). A Systematic Review on Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection and Prevention Strategies. Cancer Prevention Research. 13(5). 429–442. 12 indexed citations
7.
Sroczynski, Gaby, Nikolai Mühlberger, Beate Jahn, et al.. (2020). PCN55 Budget IMPACT of Implementing HPV Testing in Cervical Cancer Screening in Austria - a MODEL Based Analysis. Value in Health. 23. S431–S431. 1 indexed citations
8.
Rochau, Ursula, Nikolai Mühlberger, Annette Conrads‐Frank, et al.. (2019). PDB51 PREVENTION AS A PUBLIC HEALTH MEASURE: LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF A POPULATION-BASED IODINE DEFICIENCY DISEASES PREVENTION PROGRAM. Value in Health. 22. S581–S582.
9.
10.
Rajšić, Saša, Holger Gothe, Helena Hiemisch Lobo Borba, et al.. (2018). Economic burden of stroke: a systematic review on post-stroke care. The European Journal of Health Economics. 20(1). 107–134. 317 indexed citations breakdown →
11.
12.
Schlenk, Richard F., Michael Stadler, Maria M. Gabriel, et al.. (2017). Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype. Leukemia Research. 62. 84–90. 9 indexed citations
13.
Sroczynski, Gaby. (2016). LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF DIFFERENT ANTIVIRAL TREATMENTS FOR CHRONIC GENOTYPE-1 HCV INFECTION IN GERMANY INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR. 1 indexed citations
14.
Jahn, Beate, Annette Conrads‐Frank, Gaby Sroczynski, et al.. (2016). The Application of Population Models to Improve Access to Medical Innovations and Population Health – A Systematic Review. Value in Health. 19(7). A377–A377. 1 indexed citations
15.
16.
Mühlberger, Nikolai, Eveline A.M. Heijnsdijk, Christina Kurzthaler, et al.. (2014). The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening. Value in Health. 17(7). A559–A559. 1 indexed citations
17.
Rochau, Ursula, Gaby Sroczynski, Dominik Wolf‎, et al.. (2013). Medical decision analysis for first-line therapy of chronic myeloid leukemia. Leukemia & lymphoma. 55(8). 1758–1767. 4 indexed citations
18.
Krämer, Alexander, Uwe Siebert, Karl Ulrich Petry, et al.. (2010). Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany. SHILAP Revista de lepidopterología. 10 indexed citations
19.
Sroczynski, Gaby, Annette Conrads‐Frank, Ralf Schwarzer, et al.. (2009). Long-term effectiveness and cost-effectiveness of screening for Hepatitis C virus infection. European Journal of Public Health. 19(3). 245–253. 44 indexed citations
20.
Siebert, Uwe, Gaby Sroczynski, Peter Hillemanns, et al.. (2006). The German Cervical Cancer Screening Model: development and validation of a decision-analytic model for cervical cancer screening in Germany. European Journal of Public Health. 16(2). 185–192. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helga Radner Breakdown of academic impact, for papers by Paolo Angelo Cortesi Breakdown of academic impact, for papers by Ralph Brinks Breakdown of academic impact, for papers by Salahuddin Kazi Breakdown of academic impact, for papers by Christine Le Bihan-Benjamin Breakdown of academic impact, for papers by Isao Kamae Breakdown of academic impact, for papers by Fraser Cummings Breakdown of academic impact, for papers by Mitsumasa Kishimoto Breakdown of academic impact, for papers by Geraldo da Rocha Castelar Pinheiro Breakdown of academic impact, for papers by Naomi Brewer
Rankless by CCL
2026